Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
29th December 2018
An Officer of the Order of the British Empire (OBE) medal has been awarded to Donald Cameron in the Queen’s New Year Honours List 2019. The award recognises the practice's former managing director's...Read more
05th December 2018
Last month we welcomed parents of children with congenital cataracts to a coffee morning to meet others in a similar position and to discuss any concerns with our optometrists. We are also setting up ...Read more